NCT06564298 2024-08-28A Study on the Combination of Sintilimab, Ramucirumab and Chemotherapy for First-line Treatment of Gastric Cancer With Liver MetastasisThe First Affiliated Hospital with Nanjing Medical UniversityPhase 2 Not yet recruiting39 enrolled